Universal Health Services, Inc.
NYSE:UHSMedical - Care Facilities
-$5.64 today
- Market cap
- $9.38B
- Beta
- 1.08
- P/E (TTM)
- 5.7
- EPS (TTM)
- $24.90
- Dividend yield
- 0.57%
Volume 0.67M
Average 0.94M
UHS Gross Profit
Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.
Universal Health Services, Inc.NYSE: UHS
Gross Profit · Q2 FY2026 · quarter ended Jun 2026
Gross profit grows in line with its trailing trend
Q2 FY2026 gross profit of $4.21B rose 9.0% year over year, behind the +10.7% change in trailing-twelve-month gross profit. Sequentially, it rose 3.6% from the prior quarter. Over 3 fiscal years it compounded at +9.6% a year.
Context
- Gross profit amounted to 90.4% of revenue in FY2025, up 0.5 pp from a year earlier.
- Gross profit increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +9.0% toward the trailing-twelve-month pace of +10.7%.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Profit history
USD · from the income statement
- Latest · FY2025
- 15.71B USD
- Year-over-year change
- +10.3%
- 4-year CAGR
- +8.8%
| Period | Period end | Gross Profit | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 15.71B | +10.3% |
| FY2024 | 2024-12-31 | 14.24B | +11.7% |
| FY2023 | 2023-12-31 | 12.75B | +6.9% |
| FY2022 | 2022-12-31 | 11.93B | +6.3% |
| FY2021 | 2021-12-31 | 11.21B | — |
Gross Profit vs competitors
How UHS compares with its peers on the latest reported figures
- Peers report in different currencies, so gross profit is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +10.7% is the 3rd highest of 9, against a peer median of -16.1%.
- Gross profit amounts to 90.7% of revenue for UHS, versus a peer median of 29.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $22.12B USD | -25.6% | +10.6% | 28.4% | |
| LTM Jun 2026 | $16.43B USD | +10.7% | +9.6% | 90.7% | |
| LTM Mar 2026 | $11.53B USD | +118.3% | -39.6% | 53.7% | |
| LTM Jun 2026 | $5.86B USD | -53.9% | +35.5% | 26.9% | |
| LTM Jun 2026 | €5.12B EUR | +6.3% | +0.9% | 26.4% | |
ARDTArdent Health Partners, LLC | LTM Mar 2026 | $3.2B USD | -30.5% | +13.9% | 49.7% |
| LTM Jun 2026 | $789.96M USD | -6.5% | -0.3% | 30.4% | |
| LTM Mar 2026 | $417.67M USD | +37.2% | +206.6% | 47.5% | |
| LTM Sep 2026 | $376.54M USD | -85.8% | -38.5% | 11.0% | |
| Peer median (excluding UHS) | — | -16.1% | +5.8% | 29.4% | |
Competitors are the stored peer set for UHS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 12.64B | 13.4B | 14.28B | 15.83B | 17.36B |
| Cost of Revenue | 1.43B | 1.47B | 1.53B | 1.59B | 1.66B |
| Gross Profit | 11.21B | 11.93B | 12.75B | 14.24B | 15.71B |
| Gross Margin | 88.7% | 89.0% | 89.3% | 90.0% | 90.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 6.28B | 6.89B | 7.25B | 7.67B | 8.23B |
| Operating Expenses | 9.85B | 10.92B | 11.57B | 12.56B | 13.71B |
| Depreciation & Amortization | 533.21M | 581.86M | 568.04M | 584.83M | 618.74M |
| EBITDA | 1.91B | 1.58B | 1.72B | 2.27B | 2.74B |
| EBITDA Margin | 15.1% | 11.8% | 12.0% | 14.3% | 15.8% |
| Operating Income | 1.36B | 1B | 1.18B | 1.68B | 1.99B |
| Operating Margin | 10.8% | 7.5% | 8.2% | 10.6% | 11.5% |
| Interest Income | 1.6M | 378K | 572K | 1.43M | 1.19M |
| Interest Expense | 85.27M | 127.27M | 207.25M | 187.53M | 157.26M |
| Other Income / Expenses | (69.78M) | (137.3M) | (234.96M) | (183.88M) | (21.87M) |
| Income Before Tax | 1.29B | 866.26M | 940.43M | 1.5B | 1.97B |
| Pre-Tax Margin | 10.2% | 6.5% | 6.6% | 9.5% | 11.4% |
| Income Tax Expense | 305.68M | 209.28M | 221.12M | 334.83M | 460.96M |
| Net Income | 991.59M | 675.61M | 717.8M | 1.14B | 1.49B |
| Net Margin | 7.8% | 5.0% | 5.0% | 7.2% | 8.6% |
| EPS (Basic) | 11.99 | 9.23 | 10.35 | 17.16 | 23.42 |
| EPS (Diluted) | 11.82 | 9.14 | 10.23 | 16.82 | 23.10 |
| Weighted Avg Shares | 82.52M | 73.12M | 69.32M | 66.55M | 63.58M |
| Weighted Avg Shares (Diluted) | 83.69M | 73.83M | 70.13M | 67.9M | 64.46M |
Universal Health Services, Inc.
NYSE:UHS
Intrinsic Alpha fair value
Locked
Current Price
$186.07
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.